ELVN - CIK 0001672619
As of 2026-06-13, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $2.81 B, making it the #1878 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-13 | $2.81 B |
| 2026-06-12 | $2.78 B |
| 2026-06-11 | $2.54 B |
| 2026-06-10 | $2.25 B |
| 2026-05-29 | $2.41 B |
| 2026-05-28 | $2.52 B |
| 2026-05-26 | $2.55 B |
| 2026-05-25 | $2.53 B |
| 2026-05-24 | $2.53 B |
| 2026-05-22 | $2.53 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-13, Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $2.81 B, making it the #1878 most valuable US-listed company.
Enliven Therapeutics, Inc. is the #1878 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.